AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33792210 — intervention group
Group type: COMPARATOR
Intervention: Control group (oral hygiene instructions only)
Number of subjects: 82
Study 32289180 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty liver (FL)
Number of subjects: 834
Study 32289180 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonalcoholic fatty liver disease (NAFLD)
Number of subjects: 834
Study 32289180 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for FL
Number of subjects: 834
Study 32289180 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for NAFLD
Number of subjects: 834
Study 32289180 — intervention group
Group type: EXPERIMENTAL
Intervention: NASH liver-related deaths
Number of subjects: 834
Study 32289180 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-related liver disease mortality
Number of subjects: 834
Study 33580651 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (diet and exercise)
Number of subjects: 148
Study 33580651 — intervention group
Group type: COMPARATOR
Intervention: Health and wellness control intervention
Number of subjects: 148
Study 32531263 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir
Number of subjects: 0
Study 32531263 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 0
Study 33867495 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D images of real rotating objects using close-range photogrammetry (experimental group)
Number of subjects: 77
Study 33867495 — intervention group
Group type: COMPARATOR
Intervention: Traditional 2D images (control group)
Number of subjects: 77
Study 34006176 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing supplemental to a standard 6-week CR program
Number of subjects: 110
Study 34006176 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard 6-week CR program)
Number of subjects: 110
Study 34006176 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 110
Study 32687451 — intervention group
Group type: EXPERIMENTAL
Intervention: RVD (lenalidomide, bortezomib, and dexamethasone)
Number of subjects: 183
Study 35565084 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation App guided core-stability exercises (CSE) combined with conventional physiotherapy
Number of subjects: 30
Study 33245453 — intervention group
Group type: EXPERIMENTAL
Intervention: Pestalotiopsis spp. isolates (6 selected for pathogenicity tests)
Number of subjects: 120
Study 33245453 — intervention group
Group type: COMPARATOR
Intervention: Non-Pestalotiopsis isolates
Number of subjects: 120
Study 34758661 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor running on a treadmill with static video capture
Number of subjects: 32
Study 34758661 — intervention group
Group type: COMPARATOR
Intervention: Outdoor running segments obtained via drone on an outdoor track
Number of subjects: 32
Study 32450904 — intervention group
Group type: EXPERIMENTAL
Intervention: CSR blogshots
Number of subjects: 238
Study 32450904 — intervention group
Group type: COMPARATOR
Intervention: CSR plain language summaries (PLSs)
Number of subjects: 238
Study 35192656 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 168
Study 35192656 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 168
Study 33455019 — intervention group
Group type: EXPERIMENTAL
Intervention: Boston Carpal Tunnel Questionnaire (BCTQ) - Symptom Severity Subscale (SSS)
Number of subjects: 600
Study 33455019 — intervention group
Group type: EXPERIMENTAL
Intervention: Boston Carpal Tunnel Questionnaire (BCTQ) - Functional Status Subscale (FSS)
Number of subjects: 600
Study 33455019 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall BCTQ scoring
Number of subjects: 600
Study 34015014 — intervention group
Group type: EXPERIMENTAL
Intervention: TaurolockU (taurolidine heparin locks twice a week combined with taurolidine urokinase locks once a week)
Number of subjects: 68
Study 34015014 — intervention group
Group type: COMPARATOR
Intervention: Control (taurolidine heparin locks thrice weekly)
Number of subjects: 68
Study 34015014 — intervention group
Group type: EXPERIMENTAL
Intervention: TaurolockU
Number of subjects: 68
Study 34015014 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 68
Study 34172071 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory and expiratory respiratory muscle training (IEMT) for 8 weeks, consisting of 5 sets of 10 repetitions, three times a day, with increasing training loads weekly
Number of subjects: 50
Study 34172071 — intervention group
Group type: COMPARATOR
Intervention: Sham-IEMT protocol
Number of subjects: 50
Study 35998673 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal water exchange (MWE)
Number of subjects: 226
Study 35998673 — intervention group
Group type: COMPARATOR
Intervention: Left water exchange (LWE)
Number of subjects: 226
Study 33167972 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D high definition
Number of subjects: 50
Study 33167972 — intervention group
Group type: COMPARATOR
Intervention: 2D high definition
Number of subjects: 50
Study 33167972 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D system
Number of subjects: 50
Study 33167972 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D and 3D systems
Number of subjects: 50
Study 34875694 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 756
Study 32708555 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg·kg−1) for 4 days, acute intake on day 5
Number of subjects: 14
Study 34739431 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside Entertainment and Relaxation Theater (BERT)
Number of subjects: 66
Study 34739431 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 66
Study 32513307 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured decision support (nurse-led decision coaching and evidence-based patient decision aid) alongside usual care
Number of subjects: 398
Study 32513307 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 398
Study 35486411 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextualized DDI management
Number of subjects: 3772
Study 35486411 — intervention group
Group type: COMPARATOR
Intervention: Basic DDI management
Number of subjects: 3772
Study 33484864 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline 100 mg intravenously (every 12 h for two doses, then every 24 h) with optional transition to 300 mg orally after 3 days
Number of subjects: 660
Study 33484864 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg intravenously (every 24 h) with optional transition to 400 mg orally after 3 days
Number of subjects: 660
Study 32466746 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia (infraclavicular nerve block)
Number of subjects: 52
Study 32466746 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 52
Study 34690334 — intervention group
Group type: EXPERIMENTAL
Intervention: Bergamot essential oil aroma intervention
Number of subjects: 60
Study 34690334 — intervention group
Group type: COMPARATOR
Intervention: Pure water aroma (control)
Number of subjects: 60
Study 33343034 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile pump flow
Number of subjects: 52
Study 33343034 — intervention group
Group type: COMPARATOR
Intervention: Nonpulsatile pump flow
Number of subjects: 52
Study 36464891 — intervention group
Group type: EXPERIMENTAL
Intervention: Head box group
Number of subjects: 190
Study 36464891 — intervention group
Group type: COMPARATOR
Intervention: Control group (without head box)
Number of subjects: 190
Study 33420673 — intervention group
Group type: COMPARATOR
Intervention: Continuous Energy Restriction (CER) - average daily energy deficit of 500 kcal
Number of subjects: 60
Study 33420673 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting-Mimicking Diet (FMD) - 5-day low energy, sugars, and proteins, high in unsaturated fats
Number of subjects: 60
Study 33420673 — intervention group
Group type: COMPARATOR
Intervention: Continuous Energy Restriction (CER)
Number of subjects: 60
Study 33420673 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting-Mimicking Diet (FMD)
Number of subjects: 60
Study 32316007 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral left thalamic stimulation
Number of subjects: 8
Study 32316007 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral thalamic DBS
Number of subjects: 8
Study 32316007 — intervention group
Group type: EXPERIMENTAL
Intervention: Left hemisphere stimulation
Number of subjects: 8
Study 32316007 — intervention group
Group type: EXPERIMENTAL
Intervention: Right hemisphere stimulation
Number of subjects: 8
Study 32316007 — intervention group
Group type: EXPERIMENTAL
Intervention: Both sides on, left side on, right side on, both sides off
Number of subjects: 8
Study 32316007 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral approach recommended for future studies
Number of subjects: 8
Study 35881208 — intervention group
Group type: EXPERIMENTAL
Intervention: MLS laser as a manual scanning technique (10 J/cm2, area 50cm2, total energy 500 J)
Number of subjects: 60
Study 35881208 — intervention group
Group type: EXPERIMENTAL
Intervention: MLS laser using point application technique (10 J/point, 8 points, total 80 J)
Number of subjects: 60
Study 35881208 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser
Number of subjects: 60
Study 34393739 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper extremity group
Number of subjects: 37
Study 34393739 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower extremity group
Number of subjects: 37
Study 34393739 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 37
Study 32469084 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation training
Number of subjects: 107
Study 32469084 — intervention group
Group type: COMPARATOR
Intervention: Classical training on the management of pre-eclampsia
Number of subjects: 107
Study 34299972 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation-enriched care for family members
Number of subjects: 64
Study 34299972 — intervention group
Group type: COMPARATOR
Intervention: Standard Indonesian mental healthcare (Control)
Number of subjects: 64
Study 36352445 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based video game stimulating cognitive and socio-emotional skills
Number of subjects: 750
Study 36352445 — intervention group
Group type: COMPARATOR
Intervention: Tablet-based game where students draw and paint (control)
Number of subjects: 750
Study 34477455 — intervention group
Group type: EXPERIMENTAL
Intervention: Method of estimating sample size for a main cluster-randomised trial with a continuous outcome
Number of subjects: 0
Study 34477455 — intervention group
Group type: COMPARATOR
Intervention: Upper confidence limit method for sample size calculation
Number of subjects: 0
Study 32310260 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent delirium prevention intervention
Number of subjects: 10
Study 36130745 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) blockade with multimodal analgesia
Number of subjects: 50
Study 36130745 — intervention group
Group type: COMPARATOR
Intervention: Placebo ESP blockade with multimodal analgesia
Number of subjects: 50
Study 33228739 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 2 mL/kg of 20% intralipid before aortic cross-unclamping
Number of subjects: 1000
Study 33228739 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (equivalent volume to intralipid)
Number of subjects: 1000
Study 35422138 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in monounsaturated fatty acids
Number of subjects: 27548
Study 35422138 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in n-6 polyunsaturated fatty acids
Number of subjects: 27548
Study 35422138 — intervention group
Group type: COMPARATOR
Intervention: Control diet rich in saturated fatty acids
Number of subjects: 27548
Study 34154367 — intervention group
Group type: EXPERIMENTAL
Intervention: omega-3 fatty acids (4 g daily)
Number of subjects: 43
Study 34154367 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 43
Study 35614404 — intervention group
Group type: EXPERIMENTAL
Intervention: Home‐Based Multimodality Functional Recovery and Metabolic Health Enhancement Program (FES‐LC plus AE and testosterone therapy)
Number of subjects: 88
Study 35614404 — intervention group
Group type: COMPARATOR
Intervention: FES‐LC plus AE and placebo injections
Number of subjects: 88
Study 34064372 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal fat intake
Number of subjects: 146
Study 34064372 — intervention group
Group type: COMPARATOR
Intervention: Normal levels of albuminuria
Number of subjects: 146
Study 33580174 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation program with remote electrocardiographic monitoring (n=33)
Number of subjects: 71
Study 33580174 — intervention group
Group type: COMPARATOR
Intervention: Traditional hospital-based cardiac rehabilitation program (n=38)
Number of subjects: 71
Study 33124654 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist/Clinician Collaborative (PCC) group (n = 496)
Number of subjects: 996
Study 33124654 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) group (n = 500)
Number of subjects: 996
Study 33291054 — intervention group
Group type: EXPERIMENTAL
Intervention: c-MeST program
Number of subjects: 245
Study 33291054 — intervention group
Group type: COMPARATOR
Intervention: wait-list control group
Number of subjects: 245
Study 32980696 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent theta‐burst stimulation (iTBS) targeting the left DLPFC
Number of subjects: 74
Study 32980696 — intervention group
Group type: EXPERIMENTAL
Intervention: continuous theta‐burst stimulation (cTBS) targeting the left vmPFC
Number of subjects: 74
Study 32980696 — intervention group
Group type: EXPERIMENTAL
Intervention: combination of treatment protocol of Group A and Group B
Number of subjects: 74
Study 32980696 — intervention group
Group type: COMPARATOR
Intervention: sham theta‐burst stimulation
Number of subjects: 74
Study 33172409 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hospital assessment by Emergency Nurses (PENs)
Number of subjects: 4587
Study 35302389 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptinezumab 100 mg
Number of subjects: 0
Study 35302389 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptinezumab 300 mg
Number of subjects: 0
Study 35302389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32885470 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 26715
Study 32885470 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 26715
Study 35157781 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam granules (500 mg)
Number of subjects: 24
Study 35157781 — intervention group
Group type: COMPARATOR
Intervention: Oral solution of levetiracetam
Number of subjects: 24
Study 34506883 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary dandelion flower extract (DFE) at 3 g/kg
Number of subjects: 300
Study 34506883 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary dandelion flower extract (DFE) at 2 and 3 g/kg
Number of subjects: 300
Study 34506883 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary dandelion flower extract (DFE) at 3 and 4 g/kg
Number of subjects: 300
Study 34506883 — intervention group
Group type: COMPARATOR
Intervention: Control (0 g/kg DFE)
Number of subjects: 300
Study 33241157 — intervention group
Group type: EXPERIMENTAL
Intervention: High-velocity low-amplitude (HVLA) manipulation
Number of subjects: 10
Study 33241157 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle energy techniques (MET)
Number of subjects: 10
Study 33241157 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 10
Study 33836265 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel plus prednisone (group A)
Number of subjects: 95
Study 33836265 — intervention group
Group type: COMPARATOR
Intervention: Physician's choice of enzalutamide or abiraterone plus prednisone (group B)
Number of subjects: 95
Study 33836265 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline circulating tumour DNA (ctDNA) fraction above the cohort median
Number of subjects: 95
Study 33836265 — intervention group
Group type: EXPERIMENTAL
Intervention: On-treatment ctDNA increase
Number of subjects: 95
Study 33836265 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA fraction >30% at baseline
Number of subjects: 95
Study 33327947 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based, student tutor-led course (ViST)
Number of subjects: 96
Study 33327947 — intervention group
Group type: COMPARATOR
Intervention: Faculty staff-led course (FS)
Number of subjects: 96
Study 33327947 — intervention group
Group type: EXPERIMENTAL
Intervention: Video questionnaire for AU
Number of subjects: 96
Study 33327947 — intervention group
Group type: EXPERIMENTAL
Intervention: Video questionnaire for TTE
Number of subjects: 96
Study 35151715 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy (SABR) - 26 Gy in 2 weekly fractions
Number of subjects: 113
Study 35151715 — intervention group
Group type: COMPARATOR
Intervention: High dose rate (HDR) brachytherapy - 27 Gy in 2 weekly fractions
Number of subjects: 113
Study 35151715 — intervention group
Group type: EXPERIMENTAL
Intervention: SABR
Number of subjects: 113
Study 35151715 — intervention group
Group type: COMPARATOR
Intervention: HDR
Number of subjects: 113
Study 35151715 — intervention group
Group type: EXPERIMENTAL
Intervention: SABR and HDR
Number of subjects: 113
Study 33646021 — intervention group
Group type: EXPERIMENTAL
Intervention: General disinformation media literacy education
Number of subjects: 0
Study 33646021 — intervention group
Group type: EXPERIMENTAL
Intervention: Deepfake-specific media literacy education
Number of subjects: 0
Study 33646021 — intervention group
Group type: COMPARATOR
Intervention: No media literacy education
Number of subjects: 0
Study 33906005 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicidality assessed using the suicide item of the 17-item Hamilton Depression Rating Scale (HAM-D)
Number of subjects: 266
Study 33906005 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body mass index (BMI)
Number of subjects: 266
Study 33906005 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher HAM-D score
Number of subjects: 266
Study 33906005 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower C-reactive protein (CRP) level
Number of subjects: 266
Study 33906005 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased number of inpatient hospitalizations
Number of subjects: 266
Study 36053969 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib 400 mg once daily
Number of subjects: 35
Study 36053969 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 35
Study 32747973 — intervention group
Group type: EXPERIMENTAL
Intervention: Casper stents
Number of subjects: 88
Study 32747973 — intervention group
Group type: COMPARATOR
Intervention: Closed-cell stents
Number of subjects: 88
Study 32747973 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study 34534410 — intervention group
Group type: EXPERIMENTAL
Intervention: LYR-210 (2500 ?g)
Number of subjects: 67
Study 34534410 — intervention group
Group type: EXPERIMENTAL
Intervention: LYR-210 (7500 ?g)
Number of subjects: 67
Study 34534410 — intervention group
Group type: COMPARATOR
Intervention: Control (saline irrigation only)
Number of subjects: 67
Study 32130116 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Health Intervention (DHI)
Number of subjects: 61
Study 32130116 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational modules viewed
Number of subjects: 61
Study 32130116 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks completed
Number of subjects: 61
Study 32130116 — intervention group
Group type: EXPERIMENTAL
Intervention: Total log-ins
Number of subjects: 61
Study 36070357 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BoNT‐A) injection
Number of subjects: 50
Study 33458857 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest method
Number of subjects: 2332
Study 33458857 — intervention group
Group type: EXPERIMENTAL
Intervention: Boosted decision tree, support vector machine, nonparametric random forest method, and neural network models
Number of subjects: 2332
Study 32377675 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid-Hyrax
Number of subjects: 66
Study 32377675 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyrax
Number of subjects: 66
Study 32377675 — intervention group
Group type: EXPERIMENTAL
Intervention: Keles
Number of subjects: 66
Study 32236715 — intervention group
Group type: EXPERIMENTAL
Intervention: Glenohumeral injection of triamcinolone 8 weeks postoperatively
Number of subjects: 88
Study 32236715 — intervention group
Group type: COMPARATOR
Intervention: No injection postoperatively
Number of subjects: 88
Study 32236715 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study 32186028 — intervention group
Group type: EXPERIMENTAL
Intervention: TwHF cream
Number of subjects: 70
Study 32186028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35174556 — intervention group
Group type: EXPERIMENTAL
Intervention: risankizumab
Number of subjects: 0
Study 35174556 — intervention group
Group type: EXPERIMENTAL
Intervention: long-term risankizumab
Number of subjects: 0
Study 35747933 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of carbohydrate (30g) and protein (15g + 15g)
Number of subjects: 6
Study 35747933 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (30g)
Number of subjects: 6
Study 35747933 — intervention group
Group type: COMPARATOR
Intervention: Zero-calorie control
Number of subjects: 6
Study 35378149 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuranolone 30 mg
Number of subjects: 89
Study 35378149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 33653769 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual care with remote automated monitoring (RAM)
Number of subjects: 900
Study 33653769 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 900
Study 36026800 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP‐051 stimulation therapy
Number of subjects: 62